EXTON,
Pa., Oct. 7, 2024 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, today
announced its participation at CPHI Worldwide in Milan, Italy to showcase leadership and
expertise on industry challenges and trends in packaging and
containment.
This year, West will highlight its industry expertise through a
technical-focused presentation:
- Examining Contamination Control Strategy in Primary
Packaging as part of EU GMP Annex 1- Wednesday, October 9 | 2:15 - 2:40 p.m.
- Presented by Ana Kuschel, Principal, Scientific Affairs,
West
"The revisions to EU GMP Annex 1 represent a significant shift
in drug manufacturing with over 30 references to primary packaging
alone," said Cindy Reiss-Clark,
Chief Commercial Officer at West. "At West, we know a drug
manufacturer's contamination control strategy is only as strong as
its weakest link, making the quality and control of materials from
third party suppliers' critical factors to their process."
West is also a finalist for a CPHI Award in the "Heart
of Pharma" category for its partnership with Fox Chase Cancer
Center. This award recognizes companies, individuals and
initiatives which nurture philanthropic, ethical and
community-based ventures. Winners will be announced during the
awards ceremony on the opening night of CPHI on October 8.
For more information about West, please visit our website:
www.westpharma.com.
For more information about CPHI Worldwide, please
visit: CPHI Milan
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With over
10,000 team members across 50 sites worldwide, West helps support
our customers by delivering approximately 43 billion components and
devices each year.
Headquartered in Exton,
Pennsylvania, West in its fiscal year 2023 generated
$2.95 billion in net sales. West is
traded on the New York Stock Exchange (NYSE: WST) and is included
on the Standard & Poor's 500 index. For more information, visit
www.westpharma.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-to-attend-and-showcase-industry-leadership-in-packaging-and-containment-at-cphi-worldwide-conference-302268066.html
SOURCE West Pharmaceutical Services, Inc.
